journal article·2025-05Open access

Magnesium oxide coatings on thermoplastic polyurethane as a key approach to prevent catheter-associated infections

Tatiana Padrão, Fernando J. Monteiro, Susana R. Sousa, Juliana R. Dias

Ceramics International· Volume 51· Issue 12

Abstract

Central venous catheters (CVCs) are essential healthcare tools, but their use is often complicated by bacterial colonization on the catheter surface, leading to serious infections and life-threatening bloodstream complications. Current strategies, often reliant on antibiotics or antiseptics, are increasingly ineffective due to the rise of antimicrobial resistance. This study aimed to develop a novel antibacterial coating for CVCs by incorporating magnesium oxide (MgO) nanoparticles onto a thermoplastic polyurethane (TPU) film surface containing barium sulfate (BaSO 4 ). The antibacterial efficacy of these coatings was evaluated against Staphylococcus epidermidis , a major pathogen in catheter-associated infections. The results showed that MgO coatings significantly inhibited bacterial growth in a concentration-dependent manner, with 0.50 % and 1.0 % MgO concentrations achieving complete eradication of both planktonic and adherent bacteria. Importantly, the coatings exhibited excellent cytocompatibility with fibroblasts and showed no significant impact on hemolysis or blood clotting. The 0.50 % MgO coating was identified as the optimal formulation, offering the best balance of potent antibacterial activity, cytocompatibility and hemocompatibility. This approach preserves the valuable physical and chemical properties of the TPU material while providing effective antibacterial protection. The straightforward and cost-effective coating process holds significant promise for industrial scale production, paving the way for a new generation of safer and more effective CVCs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Central Venous Catheters and Hemodialysis · Acute Kidney Injury Research · Nosocomial Infections in ICU

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. Nosocomial infections: epidemiology, prevention, control and surveillance10.1016/j.apjtb.2017.01.019 ↗
2. Bowdle · 2020 · vol. 132 · 1292
3. Health care–associated infections (HAIs)10.1016/j.jen.2015.01.006 ↗
4. Zander · 2018
5. Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control10.1099/jmm.0.000032 ↗
6. Prevalence of device-associated nosocomial infections caused by gram-negative bacteria in a trauma intensive care unit in Libya10.5001/omj.2015.54 ↗
7. Device-associated infections: a macroproblem that starts with microadherence10.1086/323130 ↗
8. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters10.1128/AAC.01622-05 ↗
9. Minimising blood stream infection: developing new materials for intravascular catheters10.3390/medicines7090049 ↗
10. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies
11. Intravascular catheter-related infections: advances in diagnosis, prevention, and management10.1016/S1473-3099(07)70235-9 ↗
12. Catheter-related bloodstream infections10.4103/2229-5151.134184 ↗
13. Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)10.1007/s00277-020-04286-x ↗
14. Incidence, risk factors, and microbiology of central venous catheterization-associated bloodstream infections at a surgical tertiary intensive care unit
15. Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis
16. New materials and devices for preventing catheter-related infections10.1186/2110-5820-1-34 ↗
17. Kern · 2017
18. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis10.1016/S1473-3099(08)70280-9 ↗
19. Central venous catheters and biofilms: where do we stand in 2017?10.1111/apm.12665 ↗
20. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms10.1016/j.heliyon.2019.e02192 ↗
21. Guidelines for the prevention of intravascular catheter-related infections10.1093/cid/cir257 ↗
22. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood10.1016/j.biomaterials.2009.03.054 ↗
23. Chlorhexidine impregnated central venous catheter inducing an anaphylatic shock in the intensive care unit10.1016/j.hlc.2010.10.001 ↗
24. Antimicrobial activity of the metals and metal oxide nanoparticles10.1016/j.msec.2014.08.031 ↗
25. Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay10.1016/S0167-7012(03)00037-X ↗
26. Metal‐based nanomaterials in biomedical applications: antimicrobial activity and cytotoxicity aspects10.1002/adfm.201910021 ↗
27. Antibacterial properties of nanoparticles10.1016/j.tibtech.2012.06.004 ↗
28. Mechanisms of antibacterial activity of MgO: non‐ROS mediated toxicity of MgO nanoparticles towards Escherichia coli10.1002/smll.201302434 ↗
29. Antimicrobial activities and mechanisms of magnesium oxide nanoparticles (nMgO) against pathogenic bacteria, yeasts, and biofilms10.1038/s41598-018-34567-5 ↗
30. An insight into the mechanism of antibacterial activity by magnesium oxide nanoparticles10.1039/D1TB00875G ↗
31. MgO nanoparticles as antibacterial agent: preparation and activity10.1590/0104-6632.20140313s00002813 ↗
32. Mechanistic investigation on the toxicity of MgO nanoparticles toward cancer cells10.1039/c2jm35087d ↗
33. Dissociation of magnesium oxide and magnesium hydroxide nanoparticles in physiologically relevant fluids10.1007/s11051-018-4314-3 ↗
34. Experimental immunology Complex function of magnesium in blood clot formation and lysis10.5114/ceji.2013.35203 ↗
35. Development of lead-free radiation shielding material utilizing barium sulfate and magnesium oxide as fillers in addition cure liquid silicone rubber10.3390/polym15224382 ↗
36. Albumin and fibrinogen adsorption on PU–PHEMA surfaces10.1016/S0142-9612(03)00002-4 ↗
37. Exposure of smaller and oxidized graphene on polyurethane surface improves its antimicrobial performance10.3390/nano10020349 ↗
38. 2001
39. Wikler · 2006 · vol. 26
40. Antibacterial activities of magnesium oxide (MgO) nanoparticles against foodborne pathogens10.1007/s11051-011-0595-5 ↗
41. Antibacterial activity of MgO nanoparticles based on lipid peroxidation by oxygen vacancy10.1007/s11051-012-1063-6 ↗
42. 2011
43. 2009
44. Poly (2-hydroxyethyl methacrylate) hydrogels containing graphene-based materials for blood-contacting applications: from soft inert to strong degradable material10.1016/j.actbio.2023.04.031 ↗
45. Smaller particle size and higher oxidation improves biocompatibility of graphene-based materials10.1016/j.carbon.2015.11.076 ↗
46. Synthesis and surface properties of submicron barium sulfate particles10.1016/j.apsusc.2011.07.137 ↗
47. Study on the stability and microstructural properties of barium sulfate nanoparticles produced by nanomilling10.1016/j.apt.2013.04.003 ↗
48. Microstructural, optical and magnetic properties study of nanocrystalline MgO10.1088/2053-1591/1/2/025026 ↗
49. Inhibition of protein adsorption and cell adhesion on PNIPAAm-grafted polyurethane surface: effect of graft molecular weight10.1016/j.colsurfb.2010.10.047 ↗
50. Bacteria–surface interactions10.1039/c3sm27705d ↗
51. Fewer defects in the surface slows the hydrolysis rate, decreases the ROS generation potential, and improves the non‐ROS antimicrobial activity of MgO
52. The antibacterial and angiogenic effect of magnesium oxide in a hydroxyapatite bone substitute10.1038/s41598-020-76063-9 ↗
53. Ultrasound radiation as a “throwing stones” technique for the production of antibacterial nanocomposite textiles10.1021/am100291w ↗
54. Cotton · 2019
55. Antibacterial characteristics of magnesium oxide powder10.1023/A:1008916209784 ↗
56. 2006
57. Fabrication of electroactive nanocomposite based on carbon nanofibers/magnesium oxide nanoparticles for bone tissue engineering
58. Effect of Biofunctional Green synthesized MgO-nanoparticles on oxidative-stress-induced tissue damage and thrombosis10.3390/molecules27165162 ↗
59. Research · 2023 · 250